ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

December 13, 1996

Chart of Core Grants

October 18, 1991

Protection Commission Asks Hew To Adopt Entire Report As Policy for Human Subject Research

April 27, 1979

Rall Supports Animal Tests; Carcinogenesis Reports Summarized

May 13, 1977

Hatfield Asks AACR to Join In forming “Triangle Coalition”

June 23, 1989

Acceptance Of Sentinel Node Biopsy Is Growing, Study Finds

October 31, 2003